...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Tensha Therapeutics sold to Roche
Reply New Message
Back To Forum List View
Tensha Therapeutics sold to Roche
2
BKC
Jan 12, 2016 02:39PM

Thanks for sharing BKC. Here's a link to the new story. And Tensha's lead molecule TEN-010 is a first generation BET inhibitor, whereas Zenith will be using next generation BET inhibitors.

BearDownAZ

3 Recommendations
Re: Tensha Therapeutics sold to Roche
5
KayakerBC
Jan 12, 2016 03:03PM
Re: Tensha Therapeutics sold to Roche
4
masila
Jan 12, 2016 03:08PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply